What does CUSIP 88165N105 represent in this 13F holders report?

CUSIP 88165N105 is the security identifier for TTPH - TETRAPHASE PHARMACEUTICALS I - COM used to aggregate holder disclosures.

How many institutions held TTPH - TETRAPHASE PHARMACEUTICALS I - COM in Q2 2016?

90 institutional investors reported TTPH - TETRAPHASE PHARMACEUTICALS I - COM for Q2 2016. Use the holders table for investor-level position and value details.

TETRAPHASE PHARMACEUTICALS I - COM (TTPH)

CUSIP: 88165N105

Q2 2016 13F Holders as of 30 Jun 2016

Type / Class: Equity / COM
Total 13F shares: 21,825,025
Share change: -1,623,423
Total reported value: $93,840,092
Put/Call ratio: 215%
Price per share: $4.30
Number of holders: 90
Value change: -$7,846,673
Number of buys: 37
Number of sells: 51

Quarterly Holders Quick Answers

What is CUSIP 88165N105?
CUSIP 88165N105 identifies TTPH - TETRAPHASE PHARMACEUTICALS I - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Institutional Holders of TETRAPHASE PHARMACEUTICALS I - COM (TTPH) as of Q2 2016

As of 30 Jun 2016, TETRAPHASE PHARMACEUTICALS I - COM (TTPH) was held by 90 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 21,825,025 shares. The largest 10 holders included WELLINGTON MANAGEMENT GROUP LLP, GREAT POINT PARTNERS LLC, CANADA PENSION PLAN INVESTMENT BOARD, FMR LLC, BlackRock Fund Advisors, VANGUARD GROUP INC, BlackRock Institutional Trust Company, N.A., RENAISSANCE TECHNOLOGIES LLC, STATE STREET CORP, and GRANAHAN INVESTMENT MANAGEMENT INC/MA. This page lists 90 institutional shareholders reporting positions in this security for the Q2 2016 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.